Federal Antimonopoly Service (FAS of Russia) has issued Letter No. АЦ/49132/18 dated 29 June 2018 in which expressed its opinion regarding selling prices for drugs, included in the List of vital and essential drugs (the “Essential drug list”). FAS indicated that these prices, when set by wholesale and retail organizations, shall be dependent on the terms of their purchase.

On 24 April 2018 the Intellectual Property Court published its Decision in case A41 85807/2016 between Swiss-based Novartis AG and local generic Nativa LLC.

At present, the direction of medicine, such as telemedicine, becomes more and more known and the number of questions about the procedure of providing medical assistance using telemedicine is also growing.

The Ministry of Healthcare of the Russian Federation (the “Minzdrav”) has developed draft law aimed to improve regulation of drugs circulation, namely in respect of the determination of drugs interchangeability (the "Draft Law“).

Lidings’ Managing Partner, Head of the pharmaceuticals and healthcare industry practice of the firm Andrey Zelenin will speak at the 24th Russian Pharmaceutical Forum annually organized in Saint Petersburg by the Adam Smith Institute with Lidings’ support. The event will take place on May 15-16 traditionally hosted by one of the city’s central locations — Corinthia Hotel.

Partner of the Lidings’ Intellectual Property practice Boris Malakhov will take part in the All Russian Conference on Intellectual Property in Pharma Market: Protection of Rights and Court Practice in 2018. Organized by the Agency for Socio-Economic Development the event will take place in Moscow on April 23rd 2018 at the Balchug Kempinsky hotel.

On April 13, 2018 the draft law (hereinafter — the “Draft law”) imposing measures (countermeasures) in response to the hostile acts of the USA and (or) other foreign countries has been introduced to State Duma by both State Duma’s chairman and parliamentary leaders.

Lidings’ Managing partner, Head of the pharmaceuticals and healthcare industry practice of the firm Andrey Zelenin will speak at the conference entitled Pharmaceuticals — 2018: Legal Aspects. The event organized by Pravo.ru will take place in Moscow on April 17th at the Metropol hotel.

Lidings law firm once again takes a leading position in the ranking of the most prominent legal advisors in Russia based on the analytical research held annually by the “Kommersant” newspaper.

Reflected by the Pravo.ru’s Sympathy Rating — 2017 identifying the most prominent legal advisors in Russia based on the feedback of peers Lidings recognized as a leading firm for its expertise in employment law and pharmaceuticals and healthcare industry practice area. Individual and moreover exclusive recognition as the only recommended lawyer in this sphere, for a remarkable work for advising pharmaceutical companies in Russia, is given to Lidings’ Managing Partner, Head of the firm’s Pharmaceuticals and Healthcare industry practice, Andrey Zelenin.